Scholarlink

<p>Hepatocellular carcinoma (HCC) poses a significant global health burden due to its high incidence and mortality rates. Early diagnosis is crucial for improving patient outcomes; however, current diagnostic methods, such as the measurement of α-fetoprotein (AFP) levels, have notable limitations. Our study aimed to explore non-invasive markers with superior diagnostic efficacy for HCC. Our findings revealed a significant downregulation of FGA, FGB, and FGG in HCC, with lower expression levels strongly associated with reduced overall survival and disease-free survival rates. Notably, the diagnostic accuracies of FGA and FGB in detecting HCC, particularly in its early stages, surpassed that of AFP. ELISA results further confirmed the reduced serum levels of these proteins in HCC patients. In addition, a negative correlation was observed between fibrinogen expression and the abundance of myeloid-derived suppressor cells in HCC. FGA and FGB emerge as promising non-invasive biomarkers for HCC, offering improved diagnostic accuracy compared to AFP. Their consistent downregulation across different stages of HCC and their linkage to the tumor microenvironment underscore their potential role in HCC pathogenesis. These insights warrant further investigation and may contribute to the development of more effective diagnostic tools.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Fibrinogen alpha and beta chains as non-invasive predictors of hepatocellular carcinoma progression

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月27日

查看全文
  • Hyung Seok Kim,
  • Ji Yi Choi,
  • Se Ha Jang,
  • Minji Kang,
  • Moon Gyeong Yoon,
  • Geum Ok Baek,
  • Won Park,
  • Ji Eun Han,
  • Hyo Jung Cho,
  • Jee-Yeong Jeong,
  • Jae Youn Cheong,
  • Soon Sun Kim,
  • Jung Woo Eun

摘要

Hepatocellular carcinoma (HCC) poses a significant global health burden due to its high incidence and mortality rates. Early diagnosis is crucial for improving patient outcomes; however, current diagnostic methods, such as the measurement of α-fetoprotein (AFP) levels, have notable limitations. Our study aimed to explore non-invasive markers with superior diagnostic efficacy for HCC. Our findings revealed a significant downregulation of FGA, FGB, and FGG in HCC, with lower expression levels strongly associated with reduced overall survival and disease-free survival rates. Notably, the diagnostic accuracies of FGA and FGB in detecting HCC, particularly in its early stages, surpassed that of AFP. ELISA results further confirmed the reduced serum levels of these proteins in HCC patients. In addition, a negative correlation was observed between fibrinogen expression and the abundance of myeloid-derived suppressor cells in HCC. FGA and FGB emerge as promising non-invasive biomarkers for HCC, offering improved diagnostic accuracy compared to AFP. Their consistent downregulation across different stages of HCC and their linkage to the tumor microenvironment underscore their potential role in HCC pathogenesis. These insights warrant further investigation and may contribute to the development of more effective diagnostic tools.